Product Information
VYTORIN 10-80 MG TABLET is a brand product labeled by Organon LLC, priced at $13.1524 per EA under NDC 78206017702. Its NADAC has been published 70 times since Jul 17, 2024.
FDA first approved this application on Jul 23, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ezetimibe and simvastatin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10; 80 mg/1; mg/1
Manufacturer
Organon LLCNDC
78206017702
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
1/1/2025
Active Ingredients
EZETIMIBE; SIMVASTATINApproval Type
New Drug (NDA)
FDA Application
NDA021687FDA Approved
7/23/2004
TE Code
AB
On Market Since
6/1/2021
Pharmacological Classes
Price Statistics
The NADAC for VYTORIN 10-80 MG TABLET has been published 70 times since Jul 17, 2024, and over the history we have for it it has risen 5.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.1524 per EA |
|---|---|
| All-time high | $13.1524 (Nov 12, 2025) |
| All-time low | $12.5260 (Jul 17, 2024) |
| 52-week high | $13.1524 |
| 52-week low | $13.1524 |
| Median price | $13.1524 |
| Average price | $12.9377 |
| Largest weekly change | +5.0% (Jan 1, 2025) |
| Weeks tracked | 70 |
| Tracking since | Jul 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
N/A
5Y
N/A
All
+5.0%
Last surveyed Nov 12, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VYTORIN 10-80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VYTORIN 10-80 MG TABLET, manufactured by Organon LLC, is $13.1524 per EA (NDC 78206017702), effective Nov 12, 2025.
How has the price of VYTORIN 10-80 MG TABLET changed over time?
Over the history we have for it, the NADAC for VYTORIN 10-80 MG TABLET has risen 5.0%. It has been tracked across 70 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for VYTORIN 10-80 MG TABLET?
Since Jul 17, 2024, the NADAC for VYTORIN 10-80 MG TABLET has ranged from a low of $12.5260 (Jul 17, 2024) to a high of $13.1524 (Nov 12, 2025), with a median of $13.1524 per EA.
Are there cheaper alternatives to VYTORIN 10-80 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EZETIMIBE-SIMVASTATIN 10-80 MG, is $0.3492 per EA — about 97% below VYTORIN 10-80 MG TABLET.
Who manufactures VYTORIN 10-80 MG TABLET?
VYTORIN 10-80 MG TABLET (NDC 78206017702) is labeled by Organon LLC, and CMS classifies it as a brand product.